Peer-reviewedCC BY-NC-ND 4.0Scientific Reports
Metabolic syndrome and colorectal cancer share GPAT3 and PLAU as candidate genes: Mendelian randomisation, machine learning, single-cell knockout and docking
Related
- Cell-type-resolved colocalisation prioritises KCNIP2 as a candidate epilepsy drug-target detectable at inhibitory-neuron but not bulk-tissue resolution: a Mendelian randomisation and colocalisation study.
- Causal roles of phenotypic age and metabolic health on dementia: a Mendelian randomisation and structure learning study
- Estimating dose-response relationships for vitamin D with coronary heart disease, stroke, and all-cause mortality: observational and Mendelian randomisation analyses
- Connecting diet and disease: Using Mendelian randomisation to bridge the gap
- Evaluating Diabetes Drug Targets for Vascular Dementia Prevention Using Drug Target Mendelian Randomisation
BibTeX
@article{zhou2026metabolic,
title = {{Metabolic syndrome and colorectal cancer share GPAT3 and PLAU as candidate genes: Mendelian randomisation, machine learning, single-cell knockout and docking}},
author = {Li Zhou and Yongbin Hou and Leilei Zhang and Chengyun Han and Mingjing Liao and Jiwang Zhang},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-77972-x},
url = {https://www.nature.com/articles/s41598-026-77972-x},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Metabolic syndrome and colorectal cancer share GPAT3 and PLAU as candidate genes: Mendelian randomisation, machine learning, single-cell knockout and docking
AU - Li Zhou
AU - Yongbin Hou
AU - Leilei Zhang
AU - Chengyun Han
AU - Mingjing Liao
AU - Jiwang Zhang
PY - 2026
DA - 2026/10/24
JO - Scientific Reports
DO - 10.1038/s41598-026-77972-x
UR - https://www.nature.com/articles/s41598-026-77972-x
SN - 2045-2322
ER -